Oxford Immunotec to Present at the 37th Annual J.P. Morgan Healthcare Conference Nasdaq:OXFD

OXFORD, United Kingdom and MARLBOROUGH, Mass., Jan. 02, 2019 (GLOBE NEWSWIRE) — Oxford Immunotec Global PLC (Nasdaq:OXFD), a world, high-growth diagnostics firm, right now introduced that Dr. Peter Wrighton-Smith, Chief Executive Officer, will present at the 37th Annual J.P. Morgan Healthcare Conference on Wednesday, January 9, 2019, at 3:00 p.m. PT (6:00 p.m. ET). The convention shall be held at the Westin St. Francis Hotel in San Francisco.

A reside webcast of the presentation shall be out there on-line from the investor relations web page of the Company’s company web site at A webcast replay shall be out there roughly 24 hours after the reside presentation and shall be archived on the web site for roughly 90 days.

About Oxford Immunotec

Oxford Immunotec Global PLC is a world, high-growth diagnostics firm targeted on growing and commercializing proprietary assays for immunology and infectious illness. The Company’s T-SPOT®.TB take a look at has been accredited on the market in over 50 international locations, together with the United States, the place it has obtained pre-market approval from the Food and Drug Administration, Europe, the place it has obtained a CE mark, in addition to Japan and China. The Company is headquartered close to Oxford, U.Okay. and in Marlborough, MA.  Additional info might be discovered at

T-SPOT and the Oxford Immunotec emblem are logos of Oxford Immunotec Ltd.


For Media and Investor Inquiries:
Karen Koski
VP, Strategy and Investor Relations
Oxford Immunotec
Tel: +1 (508) 556-1377

Source link

Show More

Related Articles

Back to top button

Get SmallCapDaily's News, Research, Trade Alerts & MORE, all 100% FREE!

Enter your email address to get started. All 100% Free.

Privacy Policy: We will NEVER share, sell, barter, etc. any of our subscribers information for any reason ever! By subscribing you agree we can send you via email our free e-newsletter on stock market & finance related, articles, news and trade alerts. Further questions please contact